Search results
Added:
1 year ago
ACC 2024 — Dr Ami B Bhatt, Chief Innovation Officer of ACC, joins us to highlight key information regarding artificial intelligence innovations in cardiology in 2024.Dr Bhatt discusses the potential progress and innovation that artificial intelligence can provide in clinical medicine, including risk predictions, artificial intelligence use in EKGs, large language models and virtual learning…
View more
Added:
2 years ago
AHA 23 — Dr Michael Honigberg (Massachusetts General Hospital, US) highlights key 2023 cardiology updates, featuring novel data from AHA Scientific Sessions.Dr Honigberg provides commentary on the new SELECT trial outcomes and emphasises the incretin mimetic, semaglutide's role in cardiovascular medicine. He delves into lipid management with a focus on the CLEAR trial data and the incorporation…
View more
Added:
1 year ago
In this compelling episode of Parallax, host Ankur Kalra sits down with Dr Sharonne Hayes, a trailblazing Professor of Cardiovascular Medicine and the vice chair for academic advancement and faculty development at Mayo Clinic. Together, they explore the critical intersections of career flexibility, diversity, and inclusion in modern medicine.Drawing from her extensive experience, Dr Hayes…
View more
Added:
6 days ago
Source:
Radcliffe Cardiology
Explore free-to-access cardiology content, including expert video discussions, guideline-relevant analysis and peer-reviewed reviews designed for application in cardiovascular practice.New Horizons in Dyslipidaemia 2026On-Demand Video EventWith forthcoming updates anticipated at American College of Cardiology Annual Scientific Session, dyslipidaemia management is entering a period of refinement,…
View more
Frailty and Cardio-oncology
Added:
3 months ago
Review Article
Added:
1 year ago
HFA 24 - We are joined by Dr Muthiah Vaduganathan (Brigham and Women’s Hospital, US) to discuss the findings from a study of four large-scale placebo controlled-trials investigating the timing of cardio-kidney protection with SGLT2 inhibitors.4 trials that sampled distinct patient populations were enrolled in the trial - the CANVAS program, the CREDENCE trial, DAPA-HF and DELIVER. Across each…
View more
ACC 2026
Start date:
Mar 28, 2026
End date:
Mar 30, 2026
Event
Start date:
Mar 29, 2025
End date:
Mar 31, 2025
ACC 2025 will take place from March 29th to 31st in Chicago, IL.The American College of Cardiology (ACC) is the premier professional organization for over 54,000 cardiovascular professionals worldwide. Leading the charge in health policy formation, standards, and guidelines, the ACC is dedicated to improving cardiovascular care through national registries and professional medical education…
View more
Added:
1 year ago
Source:
Radcliffe Cardiology
AUTHOR: Greg GuilloryTwo late-breaking clinical trials addressing cardiovascular outcomes in patients with diabetes were presented this week at the American College of Cardiology meeting in Atlanta, USA. One of these trials looked at the effects of the hyperactivation of the polyol pathway on diabetic cardiomyopathy (DbCM) and the other the effects of chelation therapy in patients with diabetes…
View more
